<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Data-Review" Owner="NLM">        <PMID Version="1">30291561</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1932-2267</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>12</Volume>                    <Issue>6</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Dec</Month>                    </PubDate>                </JournalIssue>                <Title>Journal of cancer survivorship : research and practice</Title>                <ISOAbbreviation>J Cancer Surviv</ISOAbbreviation>            </Journal>            <ArticleTitle>Quality of diabetes care in breast, colorectal, and prostate cancer.</ArticleTitle>            <Pagination>                <MedlinePgn>803-812</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s11764-018-0717-5</ELocationID>            <Abstract>                <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Overlooking other medical conditions during cancer treatment and follow-up could result in excess morbidity and mortality, thereby undermining gains associated with early detection and improved treatment of cancer. We compared the quality of care for diabetes patients subsequently diagnosed with breast, colorectal, or prostate cancer to matched, diabetic non-cancer controls.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">Longitudinal cohort study using primary care records from the Clinical Practice Research Datalink, United Kingdom. Patients with pre-existing diabetes were followed for up to 5 years after cancer diagnosis, or after an assigned index date (non-cancer controls). Quality of diabetes care was estimated based on Quality and Outcomes Framework indicators. Mixed effects logistic regression analyses were used to compare the unadjusted and adjusted odds of meeting quality measures between cancer patients and controls, overall and stratified by type of cancer.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">3382 cancer patients and 11,135 controls contributed 44,507 person-years of follow-up. In adjusted analyses, cancer patients were less likely to meet five of 14 quality measures, including: total cholesterol ≤ 5 mmol/L (odds ratio [OR] = 0.82; 95% confidence interval [CI], 0.75-0.90); glycosylated hemoglobin ≤ 59 mmol/mol (adjusted OR = 0.77; 95% CI, 0.70-0.85); and albumin creatinine ratio testing (adjusted OR = 0.83; 95% CI, 0.75-0.91). However, cancer patients were as likely as their matched controls to meet quality measures for other diabetes services, including retinal screening, foot examination, and dietary review.</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Although in the short-term, cancer patients were less likely to achieve target thresholds for cholesterol and HbA1c, they continued to receive high-quality diabetes primary care throughout 5 years post diagnosis.</AbstractText>                <AbstractText Label="IMPLICATIONS FOR CANCER SURVIVORS" NlmCategory="CONCLUSIONS">These findings are important for cancer survivors with pre-existing diabetes because they indicate that high-quality diabetes care is maintained throughout the continuum of cancer diagnosis, treatment, and follow-up.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Griffiths</LastName>                    <ForeName>Robert I</ForeName>                    <Initials>RI</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-9751-8572</Identifier>                    <AffiliationInfo>                        <Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Radcliffe Primary Care Building, Radcliffe Observatory Quarter, Woodstock Road, Oxford, 0X2 6GG, UK. robert.griffiths@conted.ox.ac.uk.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, 21205, USA. robert.griffiths@conted.ox.ac.uk.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>McFadden</LastName>                    <ForeName>Emily C</ForeName>                    <Initials>EC</Initials>                    <AffiliationInfo>                        <Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Radcliffe Primary Care Building, Radcliffe Observatory Quarter, Woodstock Road, Oxford, 0X2 6GG, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Stevens</LastName>                    <ForeName>Richard J</ForeName>                    <Initials>RJ</Initials>                    <AffiliationInfo>                        <Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Radcliffe Primary Care Building, Radcliffe Observatory Quarter, Woodstock Road, Oxford, 0X2 6GG, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Valderas</LastName>                    <ForeName>Jose M</ForeName>                    <Initials>JM</Initials>                    <AffiliationInfo>                        <Affiliation>Health Services &amp; Policy Research Group and Exeter Collaboration for Primary Care (APEx), University of Exeter, Exeter, EX4 4SB, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lavery</LastName>                    <ForeName>Bernadette A</ForeName>                    <Initials>BA</Initials>                    <AffiliationInfo>                        <Affiliation>Oxford University Hospitals NHS Foundation Trust, Oxford, OX3 9DU, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Khan</LastName>                    <ForeName>Nada F</ForeName>                    <Initials>NF</Initials>                    <AffiliationInfo>                        <Affiliation>Royal Liverpool University Hospital, Liverpool, L7 8XP, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Keating</LastName>                    <ForeName>Nancy L</ForeName>                    <Initials>NL</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Health Care Policy, Harvard Medical School, Boston, 02115, USA.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Boston, 02115, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bankhead</LastName>                    <ForeName>Clare R</ForeName>                    <Initials>CR</Initials>                    <AffiliationInfo>                        <Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Radcliffe Primary Care Building, Radcliffe Observatory Quarter, Woodstock Road, Oxford, 0X2 6GG, UK.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>16609</GrantID>                    <Agency>Cancer Research UK</Agency>                    <Country>United Kingdom</Country>                </Grant>                <Grant>                    <GrantID>K24CA181510</GrantID>                    <Agency>National Cancer Institute</Agency>                    <Country/>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>10</Month>                <Day>06</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>J Cancer Surviv</MedlineTA>            <NlmUniqueID>101307557</NlmUniqueID>            <ISSNLinking>1932-2259</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2004 Oct 15;101(8):1712-9</RefSource>                <PMID Version="1">15386307</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Popul Health Manag. 2013 Feb;16(1):53-7</RefSource>                <PMID Version="1">23113633</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2013 Mar 20;31(9):1140-8</RefSource>                <PMID Version="1">23401438</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pharmacoepidemiol Drug Saf. 2010 Jun;19(6):618-26</RefSource>                <PMID Version="1">20306452</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Chronic Dis. 1987;40(5):373-83</RefSource>                <PMID Version="1">3558716</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Diabetologia. 2015 Mar;58(3):505-18</RefSource>                <PMID Version="1">25512005</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pharmacoepidemiol Drug Saf. 2009 Aug;18(8):704-7</RefSource>                <PMID Version="1">19455565</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cancer Surviv. 2010 Dec;4(4):381-7</RefSource>                <PMID Version="1">20721633</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Fam Pract. 2010 Jan 05;11:1</RefSource>                <PMID Version="1">20051110</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Med Care. 2007 Sep;45(9):869-75</RefSource>                <PMID Version="1">17712257</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Gen Intern Med. 2011 Jun;26(6):575-81</RefSource>                <PMID Version="1">21203859</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA. 2008 Dec 17;300(23):2754-64</RefSource>                <PMID Version="1">19088353</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Fam Med. 2010 Sep-Oct;8(5):418-24</RefSource>                <PMID Version="1">20843883</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Epidemiol. 2015 Jun;44(3):827-36</RefSource>                <PMID Version="1">26050254</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pharmacoepidemiol Drug Saf. 2013 Feb;22(2):168-75</RefSource>                <PMID Version="1">23239282</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Public Health. 2014 Sep;104 Suppl 4:S562-71</RefSource>                <PMID Version="1">25100422</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Gen Intern Med. 2010 Oct;25(10):1045-50</RefSource>                <PMID Version="1">20532657</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2006 Sep 20;24(27):4448-56</RefSource>                <PMID Version="1">16983113</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Diabetes Care. 2010 Jul;33(7):1674-85</RefSource>                <PMID Version="1">20587728</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Diabetes mellitus</Keyword>            <Keyword MajorTopicYN="N">Neoplasms</Keyword>            <Keyword MajorTopicYN="N">Primary health care</Keyword>            <Keyword MajorTopicYN="N">Quality indicators</Keyword>            <Keyword MajorTopicYN="N">Quality of health care</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>02</Month>                <Day>07</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>09</Month>                <Day>14</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>7</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>7</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>7</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30291561</ArticleId>            <ArticleId IdType="doi">10.1007/s11764-018-0717-5</ArticleId>            <ArticleId IdType="pii">10.1007/s11764-018-0717-5</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>